Global Blood Group Test Cards Market Strategic Research Report

Scope of the Report

The global Blood Group Test Cards market size is predicted to grow from US$ 853 million in 2025 to US$ 1,199 million in 2032; it is expected to grow at a CAGR of 5.1% from 2026 to 2032.

Blood Group Test Cards are IVD consumables that integrate ABO/Rh and related blood-group reagents into plastic cards using gel/column agglutination, glass-bead, or dry agglutination, serving pre-transfusion testing, donor screening, neonatal testing and POC / self-testing.

Supply chain – monoclonal antibodies & AHG, gel / bead matrix and plastic cards upstream; card filling and automation mid-stream; hospitals, blood banks, labs, emergency services and home users downstream.

Ex-factory prices range from US$0.1 per blank card to US$1–6 per professional test and US$15–25 per consumer kit, with typical gross margins around 45–60% in line with high-value IVD reagents.

As a fundamental tool in the blood safety assurance system, blood group test cards derive their development momentum from the efficiency demands of emergency medical scenarios, breakthroughs in technological innovation, and the continuous growth of global blood demand. In emergency medical fields, traditional blood group testing methods rely on laboratory equipment and are cumbersome to operate. In contrast, blood group test cards, with the advantage of delivering results in as little as 30 seconds, have become core equipment in resource-scarce scenarios such as field rescue, battlefield medical treatment, and disaster area healthcare. They save critical time for transfusion decisions and effectively reduce the risk of transfusion adverse reactions such as hemolysis. The upgrading of clinical medical needs has further promoted the expansion of their functions, ranging from basic ABO blood group preliminary screening to synchronous detection of ABO forward and reverse typing, Rh typing, and even rare blood group systems such as P and KELL, adapting to the precise needs of complex medical scenarios such as surgical preparation and organ transplantation. Technological innovation is one of the core driving forces. The specific combination technology of dye reagents and antigen-antibody reactions allows test results to be presented through intuitive color changes between blue-green and reddish-brown, which not only simplifies the operation process but also reduces reliance on professional operators. The integration of microfluidic technology has further improved the stability and anti-interference ability of detection. The increasing emphasis on blood safety in the global medical system, the strict regulatory requirements for blood donation and transfusion links, and the policy support from various countries for improving the diagnostic capabilities of primary medical care have collectively opened up a broad market space for blood group test cards. Their advantages in convenience and economy are particularly prominent in areas with relatively weak medical resources. However, the development of blood group test cards still faces multiple challenges. There are specific difficulties in controlling detection accuracy. Although the accuracy rate for common blood groups has reached a high level, the risk of errors caused by rare blood groups has not been completely eliminated, and there is an urgent need for large-sample verification and technical optimization. Product hierarchy differentiation brings market adaptation issues. High-end automated test cards can realize multi-system synchronous detection, but their high cost makes them difficult to popularize in primary medical institutions with limited resources; while low-end products may affect the reliability of test results due to insufficient material or reagent stability. The competitive pressure from alternative technologies is also obvious. Fully automated blood group analyzers, with their highly integrated detection capabilities, are increasingly used in large hospitals and diagnostic laboratories, and their advantages in standardized operation and batch processing have squeezed the market share of traditional manual test cards. In addition, regional differences in industry regulatory standards increase the difficulty of product internationalization. Different regions have different requirements for the sensitivity, shelf life, and clinical verification of test cards, and enterprises need to invest additional resources to make compliance adjustments. The stability of raw material supply cannot be ignored either. Quality fluctuations in core raw materials such as specific antigens and dye reagents may directly affect product performance, while supply chain fluctuations may lead to risks in production continuity. In the future, with further technological maturity, blood group test cards that combine rapid detection, multi-system adaptation, and cost advantages will become the market mainstream, playing a more critical role in improving the global blood safety system.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Blood Group Test Cards market?

What factors are driving Blood Group Test Cards market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Blood Group Test Cards market opportunities vary by end market size?

How does Blood Group Test Cards break out by Type, by Application?

This report presents a comprehensive overview of the global Blood Group Test Cards market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Universal Blood Type Test Card
• Special Blood Type Test Card

Segment by Detection Principle

• Gel / Column Agglutination Cards
• Glass-Bead & Micro-Bead Cards
• Dry Reagent Agglutination Cards
• Others

Segment by Automation

• Manual POCT Cards
• Bench-Top Incubator + Centrifuge
• Fully Automated Analyzer Cards

Segment by Application

• Household
• Hospital
• Clinic
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Blood Group Test Cards market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Household, Hospital, Clinic evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact